(E)-3-[3-(5-chlorothiophen-2-yl)-1-phenylpyrazol-4-yl]-N-[3-(1,3-dioxoisoindol-2-yl)phenyl]prop-2-enamide

C30H19ClN4O3S — CID 166435906

IUPAC(E)-3-[3-(5-chlorothiophen-2-yl)-1-phenylpyrazol-4-yl]-N-[3-(1,3-dioxoisoindol-2-yl)phenyl]prop-2-enamide
SMILESO=C(/C=C/c1cn(-c2ccccc2)nc1-c1ccc(Cl)s1)Nc1cccc(N2C(=O)c3ccccc3C2=O)c1
InChIInChI=1S/C30H19ClN4O3S/c31-26-15-14-25(39-26)28-19(18-34(33-28)21-8-2-1-3-9-21)13-16-27(36)32-20-7-6-10-22(17-20)35-29(37)23-11-4-5-12-24(23)30(35)38/h1-18H,(H,32,36)/b16-13+
InChIKeyVAXHBGRJEHPTLW-DTQAZKPQSA-N
MW551.03 g/mol
LogP6.71
Rot. Bonds6

About (E)-3-[3-(5-chlorothiophen-2-yl)-1-phenylpyrazol-4-yl]-N-[3-(1,3-dioxoisoindol-2-yl)phenyl]prop-2-enamide

(E)-3-[3-(5-chlorothiophen-2-yl)-1-phenylpyrazol-4-yl]-N-[3-(1,3-dioxoisoindol-2-yl)phenyl]prop-2-enamide (PubChem CID 166435906) has the molecular formula C30H19ClN4O3S and a molecular weight of 551.03 g/mol. Its IUPAC name is (E)-3-[3-(5-chlorothiophen-2-yl)-1-phenylpyrazol-4-yl]-N-[3-(1,3-dioxoisoindol-2-yl)phenyl]prop-2-enamide.

Molecular Properties

Compound Name(E)-3-[3-(5-chlorothiophen-2-yl)-1-phenylpyrazol-4-yl]-N-[3-(1,3-dioxoisoindol-2-yl)phenyl]prop-2-enamide
PubChem CID166435906
Molecular FormulaC30H19ClN4O3S
Molecular Weight551.03 g/mol
Exact Mass550.09
IUPAC Name(E)-3-[3-(5-chlorothiophen-2-yl)-1-phenylpyrazol-4-yl]-N-[3-(1,3-dioxoisoindol-2-yl)phenyl]prop-2-enamide
SMILESO=C(/C=C/c1cn(-c2ccccc2)nc1-c1ccc(Cl)s1)Nc1cccc(N2C(=O)c3ccccc3C2=O)c1
InChIInChI=1S/C30H19ClN4O3S/c31-26-15-14-25(39-26)28-19(18-34(33-28)21-8-2-1-3-9-21)13-16-27(36)32-20-7-6-10-22(17-20)35-29(37)23-11-4-5-12-24(23)30(35)38/h1-18H,(H,32,36)/b16-13+
InChIKeyVAXHBGRJEHPTLW-DTQAZKPQSA-N
XLogP6.71
TPSA84.30 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms39
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500551.03
LogP ≤ 56.71
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze (E)-3-[3-(5-chlorothiophen-2-yl)-1-phenylpyrazol-4-yl]-N-[3-(1,3-dioxoisoindol-2-yl)phenyl]prop-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (E)-3-[3-(5-chlorothiophen-2-yl)-1-phenylpyrazol-4-yl]-N-[3-(1,3-dioxoisoindol-2-yl)phenyl]prop-2-enamide?
The IUPAC name of (E)-3-[3-(5-chlorothiophen-2-yl)-1-phenylpyrazol-4-yl]-N-[3-(1,3-dioxoisoindol-2-yl)phenyl]prop-2-enamide (CID 166435906) is (E)-3-[3-(5-chlorothiophen-2-yl)-1-phenylpyrazol-4-yl]-N-[3-(1,3-dioxoisoindol-2-yl)phenyl]prop-2-enamide.
What is the SMILES notation for (E)-3-[3-(5-chlorothiophen-2-yl)-1-phenylpyrazol-4-yl]-N-[3-(1,3-dioxoisoindol-2-yl)phenyl]prop-2-enamide?
The canonical SMILES for (E)-3-[3-(5-chlorothiophen-2-yl)-1-phenylpyrazol-4-yl]-N-[3-(1,3-dioxoisoindol-2-yl)phenyl]prop-2-enamide is O=C(/C=C/c1cn(-c2ccccc2)nc1-c1ccc(Cl)s1)Nc1cccc(N2C(=O)c3ccccc3C2=O)c1.
What is the InChIKey of (E)-3-[3-(5-chlorothiophen-2-yl)-1-phenylpyrazol-4-yl]-N-[3-(1,3-dioxoisoindol-2-yl)phenyl]prop-2-enamide?
The InChIKey is VAXHBGRJEHPTLW-DTQAZKPQSA-N. The full InChI is InChI=1S/C30H19ClN4O3S/c31-26-15-14-25(39-26)28-19(18-34(33-28)21-8-2-1-3-9-21)13-16-27(36)32-20-7-6-10-22(17-20)35-29(37)23-11-4-5-12-24(23)30(35)38/h1-18H,(H,32,36)/b16-13+.
What are the key properties of (E)-3-[3-(5-chlorothiophen-2-yl)-1-phenylpyrazol-4-yl]-N-[3-(1,3-dioxoisoindol-2-yl)phenyl]prop-2-enamide?
(E)-3-[3-(5-chlorothiophen-2-yl)-1-phenylpyrazol-4-yl]-N-[3-(1,3-dioxoisoindol-2-yl)phenyl]prop-2-enamide has a molecular weight of 551.03 g/mol, XLogP of 6.71, 6 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-3-[3-(5-chlorothiophen-2-yl)-1-phenylpyrazol-4-yl]-N-[3-(1,3-dioxoisoindol-2-yl)phenyl]prop-2-enamide is sourced from PubChem (CID 166435906), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).